FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 11:05:25 23/05/2024 BST | ||
| 7.44 EUR / 7.5 EUR | -1.32% |
|
| Current month | -7.46% | ||
| 1 month | -18.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 7.4 | -2.25% |
| 22/05/24 | 7.57 | -9.56% |
| 21/05/24 | 8.37 | -1.18% |
| 20/05/24 | 8.47 | -4.08% |
| 17/05/24 | 8.83 | +4.25% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 08:55 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG0HJY |
| ISIN | DE000MG0HJY3 |
| Date issued | 20/03/2024 |
| Strike | 36.62 € |
| Maturity | Unlimited |
| Parity | 1.62 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.67 € |
|---|---|
| Lowest since issue | 7.4 € |
| Spread | 0.06 € |
| Spread % | 0.80% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
- Stock Market
- Certificates
- Certificat
